XML 98 R82.htm IDEA: XBRL DOCUMENT v3.8.0.1
Schedule I Condensed Balance Sheets (Details) - USD ($)
$ in Millions
Dec. 31, 2017
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Current assets:        
Cash and cash equivalents $ 11,981 $ 10,430 $ 10,923 $ 7,495
Total current assets 37,084 33,879    
Other assets 3,575 3,037    
Total assets 139,058 122,810 111,254  
Current liabilities:        
Accounts payable and accrued liabilities 15,180 13,361    
Commercial paper and current maturities of long-term debt 2,857 7,193    
Total current liabilities 50,463 49,252    
Long-term debt, less current maturities 28,835 25,777    
Long-term notes payable to subsidiaries 1,518 0    
Other liabilities 5,556 4,831    
Total liabilities 87,036 82,621    
Commitments and contingencies (Note 4)      
Shareholders’ equity:        
Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding 0 0    
Common stock, $0.01 par value - 3,000 shares authorized; 969 and 952 issued and outstanding 10 10    
Additional paid-in capital 1,703 0    
Retained earnings 48,730 40,945    
Accumulated other comprehensive loss (2,667) (2,681)    
Total liabilities and shareholders’ equity 139,058 122,810    
Parent Company [Member]        
Current assets:        
Cash and cash equivalents 359 180 $ 29 $ 559
Short-term notes receivable from subsidiaries 0 755    
Other current assets 575 140    
Total current assets 934 1,075    
Equity in net assets of subsidiaries 76,231 60,593    
Long-term notes receivable from subsidiaries 4,278 9,912    
Other assets 839 248    
Total assets 82,282 71,828    
Current liabilities:        
Accounts payable and accrued liabilities 502 452    
Current portion of notes payable to subsidiaries 466 280    
Commercial paper and current maturities of long-term debt 2,749 7,113    
Total current liabilities 3,717 7,845    
Long-term debt, less current maturities 28,318 25,657    
Other liabilities 953 52    
Total liabilities 34,506 33,554    
Shareholders’ equity:        
Preferred stock, $0.001 par value - 10 shares authorized; no shares issued or outstanding 0 0    
Common stock, $0.01 par value - 3,000 shares authorized; 969 and 952 issued and outstanding 10 10    
Additional paid-in capital 1,703 0    
Retained earnings 48,730 40,945    
Accumulated other comprehensive loss (2,667) (2,681)    
Total UnitedHealth Group shareholders’ equity 47,776 38,274    
Total liabilities and shareholders’ equity $ 82,282 $ 71,828